This webinar was on Sept. 21. Watch the recording now!


Learn about the current recommendations surrounding COVID-19 and immunocompromised individuals in this presentation by Dr. Miskulin.

Dana Miskulin, MD


Dr. Miskulin is a nephrologist at Tufts Medical Center, Boston MA. She sees patients in the ADPKD Specialty Clinic and serves as an investigator for clinical trials in ADPKD at the Tufts MC site.

Learning objective(s):

  • Understand the implications of the Delta variant of COVID.
  • Learn precautions needed against the Delta variant of COVID.
  • Discuss the current CDC recommendations regarding COVID and immunocompromised individuals.

Related Resources

Latest discoveries in ADPKD genetics

Latest discoveries in ADPKD genetics

Tuesday, September 28, 2021 | 7 p.m. CST

What is the database and what are we learning from it?

Learning Objective(s):
—Understand how genetic test results can tell us about a PKD patient’s disease progression.
—Learn how to sign up to participate in genetic research.
—Increase knowledge of PKDF’s funded research programs and projects